Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.

Modern insulin pumps are self-contained devices that attach to a user’s skin via an adhesive patch, and are responsible for administering insulin as needed. Curious as to what was inside ...

The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

Insulin solutions must be placed in an infusion pump and piggybacked into the lower distal port of a maintenance i.v. line with a rate of at least 20 mL/hr. (Use 0.9% sodium chloride injection if ...

Continuous Insulin Infusion (CSII): A method of delivering insulin continuously through a pump, allowing for more stable blood glucose levels. Infusion Set: A device used to deliver insulin from a ...

Modern insulin pumps are self-contained devices that attach to a user’s skin via an adhesive patch, and are responsible for administering insulin as needed. Curious as to what was inside ...

One of the significant advancements in diabetes management is the use of insulin pump therapy, which provides a continuous supply of insulin to help maintain stable blood glucose levels.

An insulin pump can more closely mimic the way a healthy pancreas works, through a Continuous Subcutaneous Insulin Infusion (CSII), replaces the need for frequent injections by delivering precise ...

Insulin infusion sets without pumps were also tested under a separate pressure protocol to simulate rapid decompression. This ...

Insulet has persuaded a jury that rival South Korean company EOFlow stole trade secrets relating to its wearable insulin pump technology, awarding it a whopping $452 million in damages.